Rifaximin SSD 40 mg IR tablet

DRUG2 trials

Sponsors

Bausch Health Americas, Inc., Jasmohan Bajaj

Conditions

Dementia Alzheimer TypeDementia Associated With Cerebrovascular DiseaseLiver Cirrhosis

Phase 1

Rifaximin SSD in Dementia Trial

RecruitingNCT06718686

Jasmohan BajajDementia Alzheimer Type, Dementia Associated With Cerebrovascular Disease

Start: 2024-12-30End: 2027-12-30Target: 20Updated: 2026-04-03

Phase 2

Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis

CompletedNCT01904409

Bausch Health Americas, Inc.Liver Cirrhosis

Start: 2013-06-30End: 2015-07-31Updated: 2019-10-23

Related Papers

Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials

Clinical Gastroenterology and Hepatology2022-06-2126 citations